HCA Healthcare, Inc. cash flow to debt ratio of 25.17% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

HCA Healthcare, Inc.'s free cash flow has increased 36.41% from $5.64B last year to $7.69B, signaling increasing performance

HCA Healthcare, Inc.'s debt to equity ratio is -7.42, signaling that the company spent its equity and risk bankruptcy.

HCA Healthcare, Inc.'s debt to equity ratio is -7.42, signaling that the company spent its equity and risk bankruptcy.

HCA Healthcare, Inc. has a net debt to EBITDA ratio of 3.15x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk

HCA Healthcare, Inc.'s interest coverage ratio of 5.21 indicates that earnings with good margin can cover interest payments on company debt

HCA Healthcare, Inc.'s profit margin has increased (7.47%) in the last year from 8.16% to 8.77%, signaling increasing performance

HCA Healthcare, Inc.'s short-term liabilities of $16.35B exceed its short-term assets of $13.56B, signaling financial risk

HCA Healthcare, Inc.'s return on assets of 11.30% is higher than the 5.00% threshold, indicating efficient asset utilization

HCA Healthcare, Inc.'s return on equity of -112.87%, is lower than 15.00%, indicating bad performance

HCA Healthcare, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

HCA Healthcare, Inc. had positive net income in 5 out of 5 years, indicating stable and consistent earnings

HCA Healthcare, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

HCA Healthcare, Inc. has a free cash flow yield of 8.58%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

HCA Healthcare, Inc.'s yearly earnings has increased 17.78% since last year from $5.76B to $6.78B, signaling increasing performance

HCA Healthcare, Inc.'s yearly revenue has increased 7.08% since last year from $70.60B to $75.60B, signaling increasing performance

ROIC 19.41% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

HCA Healthcare, Inc.'s 3-year revenue CAGR of 7.87% is positive, indicating growing revenue over the past 3 years

HCA Healthcare, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

HCA Healthcare, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

HCA Healthcare, Inc. is overvalued relative to its fair value price of 252.44 based on Discounted Cash Flow model

HCA Healthcare, Inc. has an earnings yield of 7.41%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

HCA Healthcare, Inc. is overvalued relative to its fair value price of 268.60 based on EBITDA multiple model

HCA Healthcare, Inc. has an EV/EBITDA ratio of 8.90x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

HCA Healthcare, Inc. is undervalued relative to its fair value price of 990.41 based on Earnings Fair Value model

HCA Healthcare, Inc. has a PEG-ratio under 1 which is considered undervalued

HCA Healthcare, Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails

HCA Healthcare, Inc. has a price-to-sales ratio of 1.18x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue